OOIR: Observatory of International Research

Papers

(The TQCC of Seminars in Immunology is 14. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-05-01 to 2024-05-01.)

Article	Citations
Outer membrane vesicle vaccines	108
The role of dendritic cells in cancer and anti-tumor immunity	100
Emerging concepts in PD-1 checkpoint biology	89
Memory CD8+ T cell responses to cancer	84
The immunology of SARS-CoV-2 infections and vaccines	82
The continued advance of vaccine adjuvants – ‘we can work it out’	75
Mutations of SARS-CoV-2 spike protein: Implications on immune evasion and vaccine-induced immunity	74
APOE mediated neuroinflammation and neurodegeneration in Alzheimer’s disease	59
New viral vectors for infectious diseases and cancer	56
T cell immunity to SARS-CoV-2	56
Key recent advances in TB vaccine development and understanding of protective immune responses against Mycobacterium tuberculosis	53
The role of neutrophil extracellular traps in cancer progression and metastasis	49
Poly-ICLC, a multi-functional immune modulator for treating cancer	46
Nanobodies in cancer	45
Functions of macrophage colony-stimulating factor (CSF1) in development, homeostasis, and tissue repair	43
G-CSF – A double edge sword in neutrophil mediated immunity	42
Non-coding RNA-based regulation of inflammation	40
Immunological approaches to HIV cure	40
Hallmarks of immune response in COVID-19: Exploring dysregulation and exhaustion	39
Transforming vaccine development	36
Epitope prediction and identification- adaptive T cell responses in humans	35
Quantum leap of monoclonal antibody (mAb) discovery and development in the COVID-19 era	33
HIV persistence in subsets of CD4+ T cells: 50 shades of reservoirs	32
HIV replication and latency in monocytes and macrophages	32
E-series resolvin metabolome, biosynthesis and critical role of stereochemistry of specialized pro-resolving mediators (SPMs) in inflammation-resolution: Preparing SPMs for long COVID-19, human clinic	32

HIV vaccinology: 2021 update	31
G-CSF, the guardian of granulopoiesis	30
The neglected brothers come of age: B cells and cancer	29
Antibody-guided structure-based vaccines	29
Broadly neutralizing antibodies for HIV-1 prevention and therapy	28
Radiotherapy: An immune response modifier for immuno-oncology	27
Macrophage regulation & function in helminth infection	27
GM-CSF: Master regulator of the T cell-phagocyte interface during inflammation	26
The dual role of neutrophils in cancer	26
Inflammation-mediated tissue damage in pulmonary tuberculosis and host-directed therapeutic strategies	26
Complement component C3: A structural perspective and potential therapeutic implications	25
The impact of immunopeptidomics: From basic research to clinical implementation	24
IL-3 in the development and function of basophils	24
Targeting GM-CSF in inflammatory and autoimmune disorders	24
Adoptive T cell therapy: Boosting the immune system to fight cancer	23
Metabolic regulation of T cells in the tumor microenvironment by nutrient availability and diet	23
Unexpected connections of the IL-23/IL-17 and IL-4/IL-13 cytokine axes in inflammatory arthritis and enthesitis	23
Colony stimulating factors in the nervous system	23
Immune response after central nervous system injury	22
Residual immune dysfunction under antiretroviral therapy	22
Tumor resident regulatory T cells	21
Dimensions of neutrophil life and fate	20
IL-33: A central cytokine in helminth infections	20
A major mechanism for immunomodulation: Dietary fibres and acid metabolites	20
Immunomodulatory effects of G-CSF in cancer: Therapeutic implications	20
Human challenge trials in vaccine development	19
Specialized pro-resolving mediators as modulators of immune responses	18
Adaptive NK cell response to human cytomegalovirus: Facts and open issues	17
Translational advances of melanocortin drugs: Integrating biology, chemistry and genetics	17
Clinical evaluation of colony-stimulating factor 1 receptor inhibitors	17
Therapeutic exploitation of neutrophils to fight cancer	16
Versatile neutrophil functions in cancer	16
Targeting dendritic cells to advance cross-presentation and vaccination outcomes	16
Heterologous humoral immunity to human and zoonotic coronaviruses: Aiming for the achilles heel	16
Innovations in lymph node targeting nanocarriers	16
Tissue-resident memory-like T cells in tumor immunity: Clinical implications	15
Pyroptosis-induced inflammation and tissue damage	14
Nanoparticles for generating antigen-specific T cells for immunotherapy	14
Pathways of MHC I cross-presentation of exogenous antigens	14